We serve Chemical Name:3-bromo-1-(4-chlorophenyl)propan-1-one CAS:33994-12-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3-bromo-1-(4-chlorophenyl)propan-1-one
CAS.NO:33994-12-6
Synonyms:3-Brom-p-chlorphenyl-propanon
Molecular Formula:C9H8BrClO
Molecular Weight:247.51600
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:328.7ºC at 760 mmHg
Density:1.522g/cm3
Index of Refraction:1.572
PSA:17.07000
Exact Mass:245.94500
LogP:3.30770
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 3-Brom-p-chlorphenyl-propanon chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Brom-p-chlorphenyl-propanon physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Brom-p-chlorphenyl-propanon Use and application,3-Brom-p-chlorphenyl-propanon technical grade,usp/ep/jp grade.
Related News: Pharmaceutical intermediates and APIs belong to the fine chemical industry. 3-bromo-1-(4-chlorophenyl)propan-1-one manufacturer Beta Bionics is pursuing regulatory approval of its insulin-only bionic pancreas, followed by its dual-hormone system, which will also administer a glucagon analog in order to raise blood-sugar levels without the need to consume carbohydrates. Beta Bionics operates in Massachusetts and California. 3-bromo-1-(4-chlorophenyl)propan-1-one supplier Pharmaceutical intermediates and APIs belong to the fine chemical industry. 3-bromo-1-(4-chlorophenyl)propan-1-one vendor Beta Bionics is pursuing regulatory approval of its insulin-only bionic pancreas, followed by its dual-hormone system, which will also administer a glucagon analog in order to raise blood-sugar levels without the need to consume carbohydrates. Beta Bionics operates in Massachusetts and California. 3-bromo-1-(4-chlorophenyl)propan-1-one factory Nearly all patients who got the vaccine developed antibodies designed to head off the spread of abnormal tau while leaving healthy tau proteins intact, Novak said.
